Pfizer May Apply for FDA Approval of COVID-19 Vaccine for Younger Children in November
In a recent speech, Pfizer’s CFO says it might be a matter of weeks for submitting an application for children 6 months to 5 years old.
Related Articles
C diff Update: The Latest in Research, Clinical Management, and Patient Advocacy
Check out the latest studies, management strategies, patient advocacy, and other important news involving this condition.
Tracking the Evolution of Clostridioides difficile and Implications for Healthcare
A study presented at ESCMID aims to understand ribotype 955 as a new challenge in C difficile management.
Cefiderocol Demonstrates Efficacy Against Pseudomonas in Immunocompromised
This cephalosporin antibiotic was examined against colistin-susceptible gram-negative infections.
Remdesivir Shows Reduction in Mortality in Seniors Hospitalized With COVID-19
A large study at ESCMID shows the therapy was associated with a significantly lower mortality at 14-days and 28-days.
Harnessing CRISPR to Battle Antimicrobial Resistance
A novel approach using this emerging technology looks to interfere with antibiotic resistance expression and reduce this global health issue.
Clinicians Often Prefer Older, Generic Antibiotics Over Newer Ones for Gram-Negative Infections
A study finds that despite the development of some new agents for highly-resistant pathogens, prescribers are reluctant to utilize these therapies.
Exploring Host-Directed Therapies for Tuberculosis
Insights into host-directed therapies (HDT) for tuberculosis (TB) gaining traction among experts aiming to combat the disease’s various forms, including drug-resistant strains.
Clinicians Often Prefer Older, Generic Antibiotics Over Newer Ones for Gram-Negative Infections
A study finds that despite the development of some new agents for highly-resistant pathogens, prescribers are reluctant to utilize these therapies.
Undernutrition is a Concerning Risk Factor for Tuberculosis in India
Insights from Pranay Sinna MD on a multicenter prospective cohort study on household contacts.
The R21/Matrix-M Vaccine: A Breakthrough in Malaria Eradication Efforts
In a collaboration between the University of Oxford, the Ministry of Health in Rwanda, and the Rwanda Biomedical Centre, groundbreaking data on the R21/Matrix-M malaria…